Literature DB >> 8780065

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

I Litvan1, Y Agid, J Jankovic, C Goetz, J P Brandel, E C Lai, G Wenning, L D'Olhaberriague, M Verny, K R Chaudhuri, A McKee, K Jellinger, J J Bartko, C A Mangone, R K Pearce.   

Abstract

We assessed the validity and interrater reliability of neurologists who, using four different sets of previously published criteria for the clinical diagnosis of progressive supranuclear palsy (PSP), also called Steele-Richardson-Olszewski syndrome, rated 105 autopsy-proven cases of PSP (n = 24), Lewy body disease (n = 29), corticobasal ganglionic degeneration (n = 10), postencephalitic parkinsonism (n = 7), multiple system atrophy (n = 16), Pick's disease (n = 7), and other parkinsonian or dementia disorders (n = 12). Cases were presented in random order to six neurologists. Information from each patient's first and last visits to the medical center supplying the case was presented sequentially to the rater, and the rater's diagnosis was compared with the neuropathologic diagnosis of each case. Interrater agreement for the diagnosis of PSP varied from substantial to near perfect, but none of the criteria had both high sensitivity and high predictive value. Because of these limitations, we used a logistic regression analysis to identify the variables from the data set that would best predict the diagnosis. This analysis identified vertical supranuclear palsy with downward gaze abnormalities and postural instability with unexplained falls as the best features for predicting the diagnosis. From the results of the regression analysis and the addition of exclusionary features, we propose optimal criteria for the clinical diagnosis of PSP.

Entities:  

Mesh:

Year:  1996        PMID: 8780065     DOI: 10.1212/wnl.46.4.922

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  60 in total

1.  LRP10 variants in progressive supranuclear palsy.

Authors:  Leonie J M Vergouw; Shamiram Melhem; Laura Donker Kaat; Wang Z Chiu; Demy J S Kuipers; Guido Breedveld; Agnita J W Boon; Li-San Wang; Adam C Naj; Elizabeth Mlynarksi; Laura Cantwell; Marialuisa Quadri; Owen A Ross; Dennis W Dickson; Gerard D Schellenberg; John C van Swieten; Vincenzo Bonifati; Frank Jan de Jong
Journal:  Neurobiol Aging       Date:  2020-04-30       Impact factor: 4.673

Review 2.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

Review 3.  Brain SPECT imaging in multiple system atrophy.

Authors:  R Cilia; G Marotta; R Benti; G Pezzoli; A Antonini
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

4.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

5.  Individual differences in socioemotional sensitivity are an index of salience network function.

Authors:  Gianina Toller; Jesse Brown; Marc Sollberger; Suzanne M Shdo; Laura Bouvet; Paul Sukhanov; William W Seeley; Bruce L Miller; Katherine P Rankin
Journal:  Cortex       Date:  2018-02-27       Impact factor: 4.027

6.  ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease.

Authors:  Cinzia Marchi; Maria Pia Adorni; Paolo Caffarra; Nicoletta Ronda; Marco Spallazzi; Federica Barocco; Daniela Galimberti; Franco Bernini; Francesca Zimetti
Journal:  J Lipid Res       Date:  2019-06-05       Impact factor: 5.922

7.  Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.

Authors:  Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

8.  Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis.

Authors:  Pyeong Hwa Kim; Da Hyun Lee; Chong Hyun Suh; Minjae Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

9.  Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy.

Authors:  Georg Nübling; M Schuberth; K Feldmer; A Giese; L M Holdt; D Teupser; S Lorenzl
Journal:  Exp Brain Res       Date:  2017-05-10       Impact factor: 1.972

Review 10.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.